Amdocs Limited
DOX
$86.74
$0.170.20%
| Weiss Ratings | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C+ | |||
| Reward Grade | B | |||
| Rating Factors | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Fair | |||
| Growth Index | Good | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.63 | |||
| Price History | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.70% | |||
| 30-Day Total Return | -8.37% | |||
| 60-Day Total Return | -7.76% | |||
| 90-Day Total Return | -0.93% | |||
| Year to Date Total Return | -3.18% | |||
| 1-Year Total Return | -6.69% | |||
| 2-Year Total Return | 4.19% | |||
| 3-Year Total Return | 9.43% | |||
| 5-Year Total Return | 62.80% | |||
| 52-Week High % Change | -13.47% | |||
| 52-Week Low % Change | 10.12% | |||
| Price | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $99.75 | |||
| 52-Week Low Price | $78.38 | |||
| 52-Week Low Price (Date) | Oct 27, 2023 | |||
| 52-Week High Price (Date) | Jun 30, 2023 | |||
| Valuation | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 10.03B | |||
| Enterprise Value | 10.28B | |||
| Price/Earnings (TTM) | 18.42 | |||
| Earnings Per Share (TTM) | 4.67 | |||
| Earnings Per Share Growth | 5.17% | |||
| Price/Earnings To Growth | 3.57 | |||
| Price/Sales (TTM) | 2.05 | |||
| Price/Book (Q) | 2.82 | |||
| Enterprise Value/Revenue (TTM) | 2.08 | |||
| Price | $85.11 | |||
| Enterprise Value/EBITDA (TTM) | 11.26 | |||
| Enterprise Value/EBIT | 14.02 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 117.54M | |||
| Dividend Yield | 2.07% | |||
| Div. Per Share (Most Recent) | $0.48 | |||
| Dividend Per Share (TTM) | $1.78 | |||
| Payout Ratio (TTM) | 36.27% | |||
| Dividend Per Share (Most Recent) | $0.48 | |||
| Company Info | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 314 212 7000 | |||
| Address | 625 Maryville Centre Drive Saint Louis, MO 63141 | |||
| Website | www.amdocs.com | |||
| Country | United States | |||
| Year Founded | 1988 | |||
| Profitability | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 14.84% | |||
| Profit Margin | 11.29% | |||
| Management Effectiveness | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 7.10% | |||
| Return on Equity | 15.62% | |||
| Income Statement | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 4.95B | |||
| Total Revenue (TTM) | 4.95B | |||
| Revenue Per Share | $42.09 | |||
| Gross Profit (TTM) | 1.73B | |||
| EBITDA (TTM) | 915.11M | |||
| EBIT (TTM) | 734.62M | |||
| Net Income (TTM) | 559.01M | |||
| Net Income Avl. to Common (TTM) | 559.01M | |||
| Total Revenue Growth (Q YOY) | 5.02% | |||
| Earnings Growth (Q YOY) | 14.51% | |||
| EPS Diluted (TTM) | 4.67 | |||
| EPS Diluted Growth (Q YOY) | 17.96% | |||
| Balance Sheet | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 600.93M | |||
| Cash Per Share (Q) | $5.11 | |||
| Total Current Assets (Q) | 1.85B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 3.60B | |||
| Current Ratio (Q) | 1.286 | |||
| Book Value Per Share (Q) | $30.56 | |||
| Total Assets (Q) | 6.47B | |||
| Total Current Liabilities (Q) | 1.44B | |||
| Total Debt (Q) | 804.36M | |||
| Total Liabilities (Q) | 2.87B | |||
| Total Common Equity (Q) | 3.56B | |||
| Cash Flow | DOX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -305.30M | |||
| Cash from Financing (TTM) | -725.78M | |||
| Net Change in Cash (TTM) | -109.29M | |||
| Levered Free Cash Flow (TTM) | 794.33M | |||
| Cash from Operations (TTM) | 921.79M | |||
